Event Participants
Executives
3
Manjunatha D.V., Pawan Kumar Jain, Suhas Donthi Manjunatha
Analysts
11
Apoorva Bahadur, Dhaval Popat, Dhruv Muchhal, Gaurav Birmiwal, Karan, Karan Gupta, Meghana, Prakhar Porwal, Rohit, Sahil Jinesh Seth, Subramaniam Yadav
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue from Operations | ₹1,555 crores | +51% YoY; driven by record quarterly production, higher manufacturing efficiencies and stronger integration benefits |
| Solar Module Production | 970 MW | +53% YoY (635 MW in Q1FY26); highest ever quarterly output; effective capacity utilization 45% vs 44% in Q1FY26 and Q4FY26 |
| Solar Cell Production | 454 MW | +26% YoY (360 MW in Q1FY26); highest ever quarterly output; utilization improved to 83% vs 68% Q1FY26 and 79% Q4FY26 |
| EBITDA | ₹548.1 crores | +56% YoY; margin 35% vs 34% Q1FY26 and 33% Q4FY26; aided by DCR-heavy mix, operating leverage and increased internal cell consumption |
| Profit After Tax | ₹380.3 crores | +103% YoY; margin 24% vs 18% Q1FY26 and 23% Q4FY26 |
| Finance Costs | ₹11.1 crores | Down sharply from ₹53.1 crores in Q1FY26 |
| EBITDA per Watt – Non-DCR Module | ₹2.0–2.5/watt | Stable QoQ and YoY; management expects continued stability with possible slight DCR improvement |
| EBITDA per Watt – DCR Module | ₹8.5–9.0/watt | Stable; DCR comprised >50% of sales mix in Q1, supporting margin expansion |
| EBITDA per Watt – Solar Cell | ₹6.0–6.5/watt | Stable despite raw material headwinds, reflecting improved operating leverage and cell efficiency |
| Order Inflow | 1,484 MW | Fresh inflows during Q1FY27 across utility-scale, C&I and rooftop segments |
| Order Book | 9.9 GW | vs 9.4 GW at end FY26; ~7+ GW executable over next 18 months |
| Installed Capacity | 10.3 GW modules; 2.94 GW TOPCon cells | Expanding to ~16.3 GW modules and ~8.9 GW cells by end FY27 |
Geographic & Segment Commentary
DCR Modules: Over 50% of Q1FY27 sales mix was DCR (including DCR cells), lifting blended EBITDA margins to 35%. ALMM List 2 implementation (June 2026) expands the DCR addressable market beyond government schemes; demand expected to strengthen progressively through FY27 as grandfathered non-DCR projects complete. Per-watt EBITDA stable at ₹8.5–9.0.
Non-DCR Modules: Production is order-linked with ~15–16 cents/watt realization. EBITDA per watt steady at ₹2.0–2.5 despite ALMM-driven market shifts, supported by bankability, quality positioning and selective customer choice. C&I demand is shifting toward DCR, with non-DCR supply expected to pick up later in FY27.
Solar Cells (Merchant): Q1FY27 recorded the highest-ever merchant cell sales in Emmvee's history — meaningful but not a dominant share of mix. Cell utilization at 83% is near the 85–90% peak; G12R transition partially completed, increasing effective capacity and supporting higher production volumes.
Company-Specific & Strategic Commentary
ALMM List 2 Preparedness: Emmvee entered the transition from a position of readiness with an operational TOPCon cell facility and inclusion under ALMM List 2, positioning it to benefit from growing demand for domestically manufactured solar cells and a tightening domestic cell supply environment.
6 GW Integrated Expansion: Module line commissioning expected December 2026, cell line March 2027. Total project cost ~₹5,500 crores (hard costs ~₹4,600 crores), with ~₹3,300 crores of debt tied up at <8%; orders representing ~60% of hard costs already placed. Post-completion capacity reaches ~16.3 GW modules and 8.9 GW cells by end FY27.
Ingot & Wafer Backward Integration: 9 GW facility planned in two phases — 5 GW in FY2029 and 4 GW in FY2030 — intended to protect margins, reduce upstream supply chain volatility and strengthen domestic cell/module economics. Largely internal-accrual funded; timing subject to ALMM List 3 clarity and market conditions.
Raw Material & Supply Chain Strategy: Strategic raw material inventory maintained given geopolitical issues. Silver import restrictions managed via DGFT pre-approvals, obtained within 3–4 days, with three-month inventory cover; pricing in line with global levels.
Technology & Digital Investments: Ongoing investments in digital technology, automation and AI to strengthen competitiveness alongside capacity expansion; G12R wafer transition partially completed with remaining conversion to proceed sequentially.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| EBITDA (FY27) | ~₹2,400 crores | Company target by close of FY27; implies increasing utilization across module and cell capacities |
| 6 GW Module Line | Commissioning December 2026 | Commercial sales to commence per commissioning schedule; utilization to scale progressively |
| 6 GW Cell Line | Commissioning March 2027 | Debt of ~₹3,300 crores tied at <8%; 60% of hard costs under order |
| Installed Capacity (End FY27) | ~16.3 GW modules; ~8.9 GW cells | Represents significant scaling from current 10.3 GW modules / 2.94 GW cells |
| Ingot & Wafer Facility | 5 GW in FY2029; 4 GW in FY2030 | Subject to ALMM List 3 clarity and prevailing market conditions; funded largely through internal accruals |
| EBITDA per Watt | Non-DCR module ₹2.0–2.5; DCR module ₹8.5–9.0; cell ₹6.0–6.5 | Stable near-term; slight DCR-side improvement possible |
| Capacity Utilization Peaks | Module ~65%; cell 85–90% | Cell already near peak at 83%; G12R transition to increase effective module capacity |
Risks & Constraints
| Risk | Context |
|---|---|
| Raw Material Cost Inflation | Silver paste and other commodity prices have been rising; management offsets via value engineering, order-linked procurement and selective pass-through — focusing on stable absolute EBITDA rather than percentage margins |
| Geopolitical Supply Chain Disruption | Management is deliberately carrying strategic raw material inventory due to geopolitical issues; silver imports require DGFT approvals, though currently processed within 3–4 days |
| ALMM List 3 Policy Uncertainty | Timing of the 9 GW ingot/wafer investment (FY29/FY30) is contingent on policy clarity; delays could defer backward integration benefits and margin protection |
| Non-DCR Market Compression | C&I and rooftop demand shifting to DCR under ALMM List 2, shrinking the non-DCR module market; management relies on bankability, quality positioning and disciplined order selection |
| Expansion Execution Risk | ₹5,500 crore project with commissioning deadlines of December 2026 (module) and March 2027 (cell); on-schedule completion critical to FY27 capacity and EBITDA targets |
Q&A Highlights
EBITDA per Watt Trends and Margin Stability
- Question: How did EBITDA per watt fare in DCR vs non-DCR segments, and what is the outlook? (Rohit, Axis Max Life)
- Answer: EBITDA spreads in both DCR and non-DCR were in line with the previous quarter; a stable scenario is expected going forward. (Suhas Manjunatha)
- Question: What is the gross margin spread trend? (Subramaniam Yadav, SBI Life)
- Answer: Management guides on EBITDA per watt rather than gross margin: ~₹2.5/watt for modules, ₹6.0–6.5/watt for cells; QoQ movement has been minimal. (Suhas Manjunatha)
DCR/Non-DCR Sales Mix
- Question: What was the DCR/non-DCR mix and how will it evolve? (Subramaniam Yadav, SBI Life)
- Answer: Over 50% of Q1 sales were DCR, reflecting in higher margins; going forward, more non-DCR modules are expected given the module-to-cell capacity gap, but comfortable DCR inventories will support coming quarters. (Suhas Manjunatha)
- Question: Does the 50% DCR mix include DCR cells sold separately? (Sahil Jinesh Seth, Anand Rathi)
- Answer: Yes, both DCR modules and DCR cells are included in the mix. (Suhas Manjunatha)
ALMM List 2 and C&I Demand
- Question: Post June 1, how has C&I demand been in order inflows, and are margins improving given solar cell tightness? (Prakhar Porwal, Ambit Capital)
- Answer: C&I order inflows have started picking up, but supply will materialize toward the later part of FY27; slight DCR margin improvement is possible, though stable margins is the more confident assumption. (Suhas Manjunatha)
Merchant Cell Sales and Margin Architecture
- Question: Are cells sold separately, and what are the margins across business models? (Apoorva Bahadur, IIFL Capital; Gaurav Birmiwal, Axis Mutual Fund)
- Answer: Merchant cell sales in Q1 were the highest in company history — meaningful but not dominant. Margin reference: non-DCR module ₹2.0–2.5/watt; cell ₹6.0–6.5/watt; DCR module ₹8.5–9.0/watt — similar whether cells are sold separately or consumed internally. (Suhas Manjunatha)
Inventory Build-up and Raw Material Costs
- Question: What is the inventory position and the reason for the sharp QoQ drop in raw materials consumed? (Apoorva Bahadur, IIFL Capital)
- Answer: ₹74.25 crores of finished goods inventory was added due to record production with LC/rain-related pick-up delays; raw material consumption was lower due to a healthier DCR mix and merchant cell sales. Inventory is expected to liquidate against the healthy 9.9 GW order book. (Pawan Jain; Suhas Manjunatha; Manjunatha D.V.)
Silver Import Regulation and Pass-through
- Question: Are there challenges from silver import restrictions, and can raw material costs be passed through? (Apoorva Bahadur, IIFL Capital; Dhaval Popat, Choice International)
- Answer: No difficulties — DGFT approvals come within 3–4 days with three-month inventory cover, at global-competitive prices. Pass-through happens in two ways: value engineering in production first, pricing pass-through second; focus remains on absolute EBITDA, not percentage margin. (Manjunatha D.V.)
FY27 EBITDA Guidance and Utilization
- Question: What module utilization should be expected, and when will ~65% be achieved? (Meghana, Old Bridge Capital)
- Answer: Base case is similar utilization levels near-term; management is targeting ~₹2,400 crores of EBITDA by close of FY27, which implies increasing utilization across both module and cell capacities. (Suhas Manjunatha)
Operating Leverage in Cell Business
- Question: Is operating leverage from higher cell utilization visible in EBITDA per watt? (Karan Gupta, Asit C. Mehta Investments)
- Answer: Per-watt EBITDA has stayed stable despite raw material headwinds (silver paste and other inputs) only because of improved operating leverage, streamlined consumption and better cell efficiency; the blended per-watt view is complicated by merchant cell sales in the mix. (Suhas Manjunatha)
Pricing Currency and Expansion Timeline
- Question: Is pricing dollar-based and when will the 6 GW expansion start contributing to order backlog? (Dhruv Muchhal, HDFC AMC; Rohit, Axis Max Life)
- Answer: Yes, all sales pricing is dollar-denominated, which largely offsets input price changes. Order book has already begun expanding — currently ~10 GW with 7+ GW executable in the next 18 months, in line with expansion plans. (Suhas Manjunatha)
Key Takeaway
Emmvee delivered a record Q1FY27: revenue of ₹1,555 crores (+51% YoY), EBITDA of ₹548.1 crores (+56% YoY, 35% margin) and PAT of ₹380.3 crores (+103% YoY), driven by record module production of 970 MW (+53% YoY) and cell production of 454 MW (+26% YoY), with cell utilization at 83% and finance costs down to ₹11.1 crores. The order book rose to 9.9 GW (1,484 MW inflows) with DCR exceeding 50% of sales, lifting margins. Management targets ~₹2,400 crores FY27 EBITDA with stable per-watt spreads (non-DCR modules ₹2.0–2.5, DCR modules ₹8.5–9.0, cells ₹6.0–6.5). The 6 GW integrated TOPCon expansion — modules by December 2026, cells by March 2027 — lifts capacity to ~16.3 GW modules and 8.9 GW cells, with ₹3,300 crores debt tied at sub-8%; a 9 GW ingot/wafer backward integration is planned in FY2029–FY2030 phases, subject to ALMM List 3 clarity. Key watch points include non-DCR demand compression, silver and raw material inflation, geopolitical supply risks, and on-schedule execution of the expansion program.